Abdulrahman AlHarbi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Abdulrahman AlHarbi has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Abdulaziz Alkudam
Division of Gastroenterology, Department of Internal Medicine, College of Medicine, Prince Sattam bin Abdulaziz University Hospital, Prince Sattam bin Abdulaziz University, Al Kharj 11942, Saudi Arabia
1 shared publication - Abdullah Hamzah Bawazir
Department of Internal Medicine, King Fahad Medical City, Riyadh, Saudi Arabia
1 shared publication - Ahmed Albadrani
Department of Internal Medicine, College of Medicine, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia
1 shared publication - Ahmed Mohammed Alghayyamah
Endoscopy Unit, Department of Internal Medicine, Arryan Hospital, Dr. Sulaiman Al Habib Ar Rayyan Hospital, Riyadh 14212, Saudi Arabia
1 shared publication - Georgios Zacharakis
Department of Internal Medicine, Division of Gastroenterology, College of Medicine, Prince Sattam Bin Abdulaziz University, Al Kharj, Saudi Arabia
1 shared publication - Majed Zaki Bahader
Endoscopy Unit, Department of Internal Medicine, Arryan Hospital, Dr. Sulaiman Al Habib Ar Rayyan Hospital, Riyadh 14212, Saudi Arabia
1 shared publication
Latest Publications
- Open Access
- 30 July 2025
- Published by MDPI AG in Current Oncology
- Vol. 32 (8) , 428
A Longitudinal Study of Premalignant Gastric Lesions and Early Onset Gastric Cancer Among Young Adults in Central Saudi Arabia
Gastric cancer traditionally affects older adults, and its precursor lesions and risk factors are well-documented in this population. Helicobacter pylori (H. pylori) infection remains highly prevalent in Saudi Arabia and contributes to gastric pathology. However, early-onset gastric cancer (EOGC), diagnosed in individuals aged ≤ 45 years, presents unique challenges and remains poorly understood in young populations. Therefore, we conducted an observational cohort study using a prospective longitudinal design (2021–2024) involving 1823 Saudi nationals aged 18–45 years who underwent zoom high-definition chromoendoscopy to evaluate the prevalence of premalignant gastric lesions (PGLs) and EOGC. We found a high H. pylori prevalence (78.0%) with PGLs in 1.9% of participants and EOGC-adenocarcinoma in 0.7% of patients. All EOGC cases arose from dysplasia, with most PGLs being classified as OLGA/OLGIM stage II/III. Multiple risk factorswere significantly associated with PGLs and EOGC, including H. pylori infection (p = 0.022), increasing age (p < 0.001), a family history of gastric cancer (p < 0.001), poor dietary habits (p < 0.001), obesity (p < 0.001), and smoking (p < 0.001). Additional EOGC risk factors include dage of 36–45 years (p = 0.018), EBV infection (p = 0.016), and diabetes mellitus (p = 0.001). These findings demonstrate the notable presence of PGLs and EOGC in young Saudi adults and emphasize the importance of early detection and risk factor management in this vulnerable population.
- 30 July 2025
- Published by MDPI AG in Current Oncology
- Vol. 32 (8) , 428
Open AccessA Longitudinal Study of Premalignant Gastric Lesions and Early Onset Gastric Cancer Among Young Adults in Central Saudi Arabia
Gastric cancer traditionally affects older adults, and its precursor lesions and risk factors are well-documented in this population. Helicobacter pylori (H. pylori) infection remains highly prevalent in Saudi Arabia and contributes to gastric pathology. However, early-onset gastric cancer (EOGC), diagnosed in individuals aged ≤ 45 years, presents unique challenges and remains poorly understood in young populations. Therefore, we conducted an observational cohort study using a prospective longitudinal design (2021–2024) involving 1823 Saudi nationals aged 18–45 years who underwent zoom high-definition chromoendoscopy to evaluate the prevalence of premalignant gastric lesions (PGLs) and EOGC. We found a high H. pylori prevalence (78.0%) with PGLs in 1.9% of participants and EOGC-adenocarcinoma in 0.7% of patients. All EOGC cases arose from dysplasia, with most PGLs being classified as OLGA/OLGIM stage II/III. Multiple risk factorswere significantly associated with PGLs and EOGC, including H. pylori infection (p = 0.022), increasing age (p < 0.001), a family history of gastric cancer (p < 0.001), poor dietary habits (p < 0.001), obesity (p < 0.001), and smoking (p < 0.001). Additional EOGC risk factors include dage of 36–45 years (p = 0.018), EBV infection (p = 0.016), and diabetes mellitus (p = 0.001). These findings demonstrate the notable presence of PGLs and EOGC in young Saudi adults and emphasize the importance of early detection and risk factor management in this vulnerable population.